These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14680815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
    Pettersson K, Delaunay F, Gustafsson JA.
    Oncogene; 2000 Oct 12; 19(43):4970-8. PubMed ID: 11042684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y, Shibata J, Yonekura K, Sato K, Hashimoto A, Aoyagi Y, Wierzba K, Yano S, Asao T, Buzdar AU, Terada T.
    Clin Cancer Res; 2005 Jan 01; 11(1):315-22. PubMed ID: 15671561
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
    Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV.
    Mol Endocrinol; 2000 Mar 01; 14(3):369-81. PubMed ID: 10707955
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 8. ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells.
    Chen M, Ni J, Zhang Y, Muyan M, Yeh S.
    Prostate; 2008 Sep 01; 68(12):1273-82. PubMed ID: 18563714
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound estrogen receptor alpha.
    Nagayama K, Sasaki S, Matsushita A, Ohba K, Iwaki H, Matsunaga H, Suzuki S, Misawa H, Ishizuka K, Oki Y, Noh JY, Nakamura H.
    J Endocrinol; 2008 Oct 01; 199(1):113-25. PubMed ID: 18653622
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z, Shi HY, Nawaz Z, Zhang M.
    Cancer Lett; 2004 Jun 08; 209(1):55-65. PubMed ID: 15145521
    [Abstract] [Full Text] [Related]

  • 13. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS, Tobias JH, Rivers C, Caunt CJ, Norman MR, McArdle CA.
    Bone; 2009 Jan 08; 44(1):102-12. PubMed ID: 18976723
    [Abstract] [Full Text] [Related]

  • 14. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment.
    Zhao C, Toresson G, Xu L, Koehler KF, Gustafsson JA, Dahlman-Wright K.
    Biochemistry; 2005 Jun 07; 44(22):7936-44. PubMed ID: 15924412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R, Penot G, Flouriot G, Pakdel F.
    Mol Endocrinol; 2001 Nov 07; 15(11):1953-70. PubMed ID: 11682626
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cloning and functional characterization of PELP1/MNAR promoter.
    Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK.
    Gene; 2004 Apr 14; 330():115-22. PubMed ID: 15087130
    [Abstract] [Full Text] [Related]

  • 19. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB, Zhao C, Deighton-Collins S, Kleerekoper M, Benjamins JA, Skafar DF.
    J Neuroendocrinol; 2007 Dec 14; 19(12):958-65. PubMed ID: 18001325
    [Abstract] [Full Text] [Related]

  • 20. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS, Jordan VC.
    Mutat Res; 2005 Dec 11; 591(1-2):247-63. PubMed ID: 16083919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.